Stock Events

Stock Events

Kala Bio 

$1.1750
75
-$0.18-12.96% Friday 20:00
+$0.02+2.13%Friday 22:53After hours

Statistics

Day High
1.185
Day Low
1.17
52W High
1,030
52W Low
1.16
Volume
4,498
Avg. Volume
-
Mkt Cap
21.84M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

6AugExpected
Q2 2024
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-8.5
-6
-3.51
-1.01
Expected EPS
-6
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-77.02MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow KALA. It's not an investment recommendation.
Tesla
10
TSLA
Apple
9
AAPL
Amazon
9
AMZN
NVIDIA
9
NVDA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.59B
Regeneron Pharmaceuticals competes in the ophthalmology space with treatments for eye diseases, directly competing with Kala's eye care products.
Novartis
NVS
Mkt Cap305.1B
Novartis offers a range of eye care medications, including treatments for conditions that Kala Bio targets, making them a direct competitor.
Abbvie
ABBV
Mkt Cap461.26B
AbbVie, through its acquisition of Allergan, has a strong presence in the ophthalmology market, competing with Kala Bio's eye care solutions.
Bausch Health Companies
BHC
Mkt Cap1.83B
Bausch Health Companies, formerly Valeant Pharmaceuticals, has a significant portfolio in eye health, competing in the same market as Kala Bio.
Biogen
BIIB
Mkt Cap31.91B
Biogen has a focus on specialty care and biologics that could compete with Kala Bio's treatments in certain niche markets.
Regenxbio
RGNX
Mkt Cap686.54M
REGENXBIO is a biotechnology company focused on the development of gene therapies for eye diseases, directly competing with Kala Bio's approach to eye care.
Gilead Sciences
GILD
Mkt Cap162.98B
Gilead Sciences, while primarily known for its work in antiviral drugs, has ventured into other therapeutic areas that could potentially compete with Kala Bio's niche markets.

About

Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the creation and commercialization of new therapeutic solutions. The core of their strategy involves utilizing proprietary nanoparticle technology, specifically mucus penetrating particles (MPPs). Initially, their focus for these treatments is directed towards ophthalmic diseases. The company was established in 2009 by co-founders Justin Hanes, Robert S. Langer, and Colin R. Gardner, and its headquarters are located in Arlington, Massachusetts.
Show more...
CEO
Ms. Mary Reumuth CPA
Employees
38
Country
United States
ISIN
US4831193010

Listings

F
DE
27F.F
XNAS
US
KALA
LSE
GB
0JQ2.LSE
BOATS
BOATS
KALA.BOATS

0 Comments

Share your thoughts

FAQ

What is Kala Bio stock price today?▼
The current price of KALA is $1.18 USD — it has decreased by -12.96% in the past 24 hours. Watch Kala Bio stock price performance more closely on the chart.
What is Kala Bio stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Kala Bio stocks are traded under the ticker KALA.
Is Kala Bio stock price growing?▼
KALA stock has fallen by -30.06% compared to the previous week, the month change is a -52.43% fall, over the last year Kala Bio has showed a -99.6% decrease.
What is Kala Bio market cap?▼
Today Kala Bio has the market capitalization of 21.84M
When is the next Kala Bio earnings date?▼
Kala Bio is going to release the next earnings report on August 06, 2026.
What is Kala Bio revenue for the last year?▼
Kala Bio revenue for the last year amounts to 0 USD.
What is Kala Bio net income for the last year?▼
KALA net income for the last year is -77.02M USD.
How many employees does Kala Bio have?▼
As of July 11, 2026, the company has 38 employees.
In which sector is Kala Bio located?▼
Kala Bio operates in the Health & Wellness sector.
When did Kala Bio complete a stock split?▼
The last stock split for Kala Bio was on May 11, 2026 with a ratio of 1:50.
Where is Kala Bio headquartered?▼
Kala Bio is headquartered in Arlington, United States.